{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:29:42Z","timestamp":1758634182233},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1991,11,1]],"date-time":"1991-11-01T00:00:00Z","timestamp":688953600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1991,11]]},"DOI":"10.1007\/bf01698375","type":"journal-article","created":{"date-parts":[[2005,6,10]],"date-time":"2005-06-10T20:08:25Z","timestamp":1118434105000},"page":"259-263","source":"Crossref","is-referenced-by-count":7,"title":["In vivo induction of HLA molecules in patients with myeloproliferative syndrome during IFN\u03b1 treatment"],"prefix":"10.1007","volume":"63","author":[{"given":"C. A.","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Walz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Zinser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. J.","family":"B\u00fchring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Steinke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01698375_CR1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0198-8859(90)90093-5","volume":"27","author":"D Abi-Hanna","year":"1990","unstructured":"Abi-Hanna D, Wakefield D (1990) Differential enhancement of HLA-B27 by interferon. Hum Immunol 27: 33\u201339","journal-title":"Hum Immunol"},{"key":"BF01698375_CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0092-8674(78)90296-9","volume":"14","author":"CJ Barnstable","year":"1978","unstructured":"Barnstable CJ, Bodmer WF, Brown G, Galfr G, Milstein C, Williams AF, Ziegler A (1978) Production of monoclonal antibodies to group-A erythrocytes, HLA and other human cell surface antigens \u2014 new tools for genetic analysis. Cell 14: 9\u201320","journal-title":"Cell"},{"issue":"Suppl A","key":"BF01698375_CR3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0305-7372(88)90069-2","volume":"15","author":"DE Bergsagel","year":"1988","unstructured":"Bergsagel DE (1988) Interferon \u03b1-2b in the management of chronic granulocytic leukemia. Cancer Treat Rep 15 [Suppl A]: 15\u201320","journal-title":"Cancer Treat Rep"},{"key":"BF01698375_CR4","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1002\/j.1460-2075.1985.tb04014.x","volume":"4","author":"OR Burrone","year":"1985","unstructured":"Burrone OR, Kefford RF, Gilmore D, Milstein C (1985) Stimulation of HLA-A, B, C by IFN-\u03b1. The derivation of Molt 4 variants and the differential expression of HLA-A, B, C subsets. EMBO J 4: 2855\u20132860","journal-title":"EMBO J"},{"key":"BF01698375_CR5","first-page":"14","volume":"29","author":"TE Eric","year":"1990","unstructured":"Eric TE, Scornik JC, Davis G, Kao KJ (1990) Induction of erythrocyte HLA expression during interferon treatment and HIV infection. Hum Immunol 29: 14\u201322","journal-title":"Hum Immunol"},{"key":"BF01698375_CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00320105","volume":"56","author":"G Gastl","year":"1988","unstructured":"Gastl G, Huber C (1988) The biology of interferon actions. Blut 56: 193\u2013199","journal-title":"Blut"},{"key":"BF01698375_CR7","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1182\/blood.V72.3.1048.bloodjournal7231048","volume":"72","author":"VH Gressler","year":"1988","unstructured":"Gressler VH, Weinkauff RE, Franklin WA, Golomb HM (1988) Modulation of the expression of major histocompatibility antigens on splenic hairy cells \u2014 differential effect upon in vitro treatment with \u03b1-2b-interferon, \u03b3-interferon, and interleukin-2. Blood 72: 1048\u20131053","journal-title":"Blood"},{"key":"BF01698375_CR8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4049\/jimmunol.142.1.297","volume":"142","author":"R Hakem","year":"1989","unstructured":"Hakem R, Le Bouteiller P, Barad M, Trujillo M, Mercier P, Wietzerbin J, Lemonnier FA (1989) IFN-mediated differential regulation of the expression of HLA-B7 and HLA-A 3 class-I genes. J Immunol 142: 297\u2013305","journal-title":"J Immunol"},{"key":"BF01698375_CR9","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/BF01757211","volume":"64","author":"E Heidemann","year":"1986","unstructured":"Heidemann E, Weber J, Schmidt H, Reichmann U (1986) Recombinant interferon\u03b1 2 stimulation of target-binding by natural killer cells. Klin Wochenschr 64: 1036\u20131040","journal-title":"Klin Wochenschr"},{"key":"BF01698375_CR10","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1073\/pnas.75.12.6215","volume":"75","author":"I Heron","year":"1978","unstructured":"Heron I, Hokland M, Berg K (1978) Enhanced expression of \u03b2 2-microglobulin and HLA antigens on human lymphoid cells by interferon. Proc Natl Acad Sci USA 75: 6215\u20136219","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01698375_CR11","first-page":"2480","volume":"42","author":"E Lotzova","year":"1982","unstructured":"Lotzova E, Savary CA, Gutterman JU, Hersh EM (1982) Modulation of natural killer cell-mediated cytotoxicity by partially purified and cloned interferon-\u03b1. Cancer Res 42: 2480\u20132488","journal-title":"Cancer Res"},{"key":"BF01698375_CR12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0198-8859(83)90092-7","volume":"6","author":"C M\u00fcller","year":"1983","unstructured":"M\u00fcller C, Liangru S, Schneider M, Ziegler A, Wernet P (1983) A cytotoxic monoclonal IgM antibody (T\u00fc 101) directed against an antigenic determinant shared between the HLA-A allospecificities A2 and A28. Hum Immunol 6: 189\u2013197","journal-title":"Hum Immunol"},{"key":"BF01698375_CR13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0171-2985(85)80036-X","volume":"169","author":"C M\u00fcller","year":"1985","unstructured":"M\u00fcller C, Ziegler A, Muller C, Hadam M, Waller HD, Wernet P, M\u00fcller G (1985) Divergent expression of HLA-DC\/MB, -DR, and -SB region products on normal and pathological tissues as detected by monoclonal antibodies. Immunobiology 169: 228\u2013249","journal-title":"Immunobiology"},{"key":"BF01698375_CR14","first-page":"1013","volume":"90","author":"GA M\u00fcller","year":"1984","unstructured":"M\u00fcller GA, M\u00fcller C, Risler T (1984) Charakterisierung glomerul\u00e4rer Halbmonde bei rapid progressiver Glomerulonephritis (RPGN) mit Hilfe monoklonaler Antik\u00f6rper. Verh Dtsch Ges Inn Med 90: 1013\u20131016","journal-title":"Verh Dtsch Ges Inn Med"},{"key":"BF01698375_CR15","first-page":"29","volume":"14","author":"N Niederle","year":"1987","unstructured":"Niederle N, Kloke O, Osieka R, Wandl U, Opalka B, Schmidt CG (1987) Interferon \u03b1-2b in the treatment of chronic myelogenous leukemia. Semin Oncol 14: 29\u201335","journal-title":"Semin Oncol"},{"key":"BF01698375_CR16","first-page":"632","volume":"69","author":"MH Nissen","year":"1987","unstructured":"Nissen MH, Larsen JK, Plesner T, Olesen BK, Ernst P (1987) \u03b1-interferon induces enhanced expression of HLA-ABC antigens and \u03b2 2-microglobulin in vivo and in vitro in various subsets of human lymphoid cells. Clin Exp Immunol 69: 632\u2013638","journal-title":"Clin Exp Immunol"},{"key":"BF01698375_CR17","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1146\/annurev.bi.56.070187.003455","volume":"56","author":"S Pestka","year":"1987","unstructured":"Pestka S, Langer JA, Zoon KC, Samuel CE (1987) Interferons and their actions. Ann Rev Biochem 56: 727\u2013777","journal-title":"Ann Rev Biochem"},{"key":"BF01698375_CR18","first-page":"47","volume":"7","author":"FM Rosa","year":"1986","unstructured":"Rosa FM, Cochet MM, Fellous M (1986) Interferon and major histocompatibility complex genes: a model to analyse eukaryotic gene regulation? Interferon 7: 47\u201387","journal-title":"Interferon"},{"key":"BF01698375_CR19","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0002-9343(86)90360-8","volume":"81","author":"TE Roth","year":"1986","unstructured":"Roth TE, Foon KA (1986) \u03b1-interferon in the treatment of hematologic malignancies. Am J Med 81: 871\u2013882","journal-title":"Am J Med"},{"key":"BF01698375_CR20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0171-2985(87)80084-0","volume":"174","author":"H Schmidt","year":"1987","unstructured":"Schmidt H, Forsthuber T, B\u00fchring H-J, M\u00fcller CA (1987) Differential expression of the HLA-B 7 and HLA-A 2 gene in transfected mouse L (tk-) cells after stimulation by mouse interferon. Immunobiology 174: 51\u201366","journal-title":"Immunobiology"},{"key":"BF01698375_CR21","first-page":"257","volume":"10","author":"H Schmidt","year":"1989","unstructured":"Schmidt H, Steinke B, Zinser R, Frese G, Gehr C, Gekeler V, Waller HD (1989) Interferon-\u03b1 in the treatment of chronic myeloid leukemia and essential thrombocytosis: differences in response rate between untreated patients and patients pretreated with busulfan. Tumor Diagn Ther 10: 257\u2013261","journal-title":"Tumor Diagn Ther"},{"key":"BF01698375_CR22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00204896","volume":"31","author":"H Schmidt","year":"1990","unstructured":"Schmidt H, Gekeler V, Haas H, Engler-Blum G, Steiert I, Probst H, M\u00fcller CA (1990) Differential regulation of HLA class-I genes by interferon. Immunogenetics 31: 245\u2013252","journal-title":"Immunogenetics"},{"key":"BF01698375_CR23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1399-0039.1986.tb01521.x","volume":"27","author":"G Spring","year":"1986","unstructured":"Spring G, Pawelec G, Ziegler A (1986) Gamma ray-induced mutants as a tool for the production and characterization of monoclonal antibodies against HLA alloantigens. Tissue Antigens 27: 201\u2013208","journal-title":"Tissue Antigens"},{"key":"BF01698375_CR24","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1182\/blood.V62.3.689.689","volume":"62","author":"M Talpaz","year":"1983","unstructured":"Talpaz M, McCredie KB, Mavligit GM, Gutterman JU (1983) Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia. Blood 62: 689\u2013692","journal-title":"Blood"},{"key":"BF01698375_CR25","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2141.1985.tb07464.x","volume":"60","author":"M Talpaz","year":"1985","unstructured":"Talpaz M, Trujillo JM, Hittelman WN, Keating MJ, Gutterman JU (1985) Suppression of clonal evolution in two chronic myelogenous leukaemia patients treated with leucocyte interferon. Br J Haematol 60: 619\u2013624","journal-title":"Br J Haematol"},{"key":"BF01698375_CR26","first-page":"62","volume":"25","author":"M Talpaz","year":"1988","unstructured":"Talpaz M, Kantarijan H, Kurzrock R, Gutterman J (1988) Therapy of chronic myelogenous leukemia: chemotherapy and interferons. Semin Hematol 25: 62\u201373","journal-title":"Semin Hematol"},{"key":"BF01698375_CR27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.iy.06.040188.002043","volume":"6","author":"K Tanaka","year":"1988","unstructured":"Tanaka K, Yoshioka T, Bieberich C, Jay G (1988) Role of the major histocompatibility complex class-I antigens in tumor growth and metastasis. Ann Rev Immunol 6: 359\u2013380","journal-title":"Ann Rev Immunol"},{"key":"BF01698375_CR28","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/304358a0","volume":"304","author":"AJ Watson","year":"1983","unstructured":"Watson AJ, DeMars R, Towbridge IS, Bach FH (1983) Detection of a novel human class-II HLA-antigen. Nature 304: 358\u2013361","journal-title":"Nature"},{"key":"BF01698375_CR29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00364765","volume":"19","author":"SY Yang","year":"1984","unstructured":"Yang SY, Morishima Y, Collins NH, Alton T, Pollack MS, Yunis EJ, Dupont B (1984) Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and -B allotypes. Immunogenetics 19: 217\u2013231","journal-title":"Immunogenetics"},{"key":"BF01698375_CR30","unstructured":"Ziegler A, Heinig J, M\u00fcller C, Gitz H, Thinnes FP, Uchanska-Ziegler B, Wernet P (1986) Analysis by sequential immunoprecipitations of the specificities of the monoclonal antibodies T\u00fc 22, 34, 36, 37, 39, 43, 58 and YD 1\/63.HLK directed against human HLA class-II antigens. Immunobiology 171-77-92"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01698375.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01698375\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01698375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T10:08:28Z","timestamp":1683108508000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01698375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,11]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1991,11]]}},"alternative-id":["BF01698375"],"URL":"https:\/\/doi.org\/10.1007\/bf01698375","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,11]]}}}